Oral contraceptives: their mode of action and dermatologic applications.
暂无分享,去创建一个
[1] H. Gollnick,et al. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment. , 2004, Cutis.
[2] A. Balen,et al. An observational study of Yasmin® in the management of women with polycystic ovary syndrome , 2004, Journal of Family Planning and Reproductive Health Care.
[3] R. Sitruk-Ware. Pharmacological profile of progestins. , 2004, Maturitas.
[4] A. Schindler. Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception. , 2004, European journal of obstetrics, gynecology, and reproductive biology.
[5] D. Thiboutot,et al. Update and Future of Hormonal Therapy in Acne , 2003, Dermatology.
[6] I. Thorneycroft. Evolution of progestins. Focus on the novel progestin drospirenone. , 2002, The Journal of reproductive medicine.
[7] E. Posvar,et al. Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol. , 2001, Contraception.
[8] L. Falsetti,et al. Management of Hirsutism , 2000, American journal of clinical dermatology.
[9] D. Lookingbill,et al. Frequency of pregnancy in acne patients taking oral antibiotics and oral contraceptives. , 1994, Archives of dermatology.